Previous close | 2.7200 |
Open | 2.9000 |
Bid | 2.2500 |
Ask | 3.5000 |
Strike | 5.00 |
Expiry date | 2024-05-17 |
Day's range | 2.9000 - 2.9000 |
Contract range | N/A |
Volume | |
Open interest | 22 |
Oramed Pharmaceuticals ( NASDAQ:ORMP ) First Quarter 2024 Results Key Financial Results Net income: US$1.54m (up from...
PALO ALTO, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that it has paid off the remaining balance of approx. $1,300,000 under the convertible debentures (the “Convertible Debentures”) previously issued and sold to YA II PN, Ltd. (“Yorkville”) in March 2023. Sci
Oramed Pharmaceuticals ( NASDAQ:ORMP ) Full Year 2023 Results Key Financial Results Net income: US$5.53m (up from...